Prevalence of adenomyosis in endometrial cancer patients: a systematic review and meta-analysis.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
01 2021
Historique:
received: 24 06 2020
accepted: 13 10 2020
pubmed: 25 10 2020
medline: 18 2 2021
entrez: 24 10 2020
Statut: ppublish

Résumé

Several studies have assessed the histological co-existence of endometrial carcinoma (EC) and adenomyosis. However, the significance of this association is still unclear. To assess the prevalence of adenomyosis in women with EC for a better understanding of the association between the two diseases. A systematic review and meta-analysis was performed by searching electronics databases from their inception to March 2020, for all studies that allowed extraction of data about prevalence of adenomyosis in EC patients. Adenomyosis prevalence was calculated for each included study and as pooled estimate, with 95% confidence interval (CI). Eight retrospective cohort studies assessing 5573 EC patients were included in our analysis. Of total, 1322 were patients with adenomyosis, and 4251 were patients without adenomyosis. Pooled prevalence of adenomyosis in EC patients was 22.6% (95% CI 12.7-37.1%). Adenomyosis prevalence in EC patients was not different from that reported for other gynecological conditions. The supposed association between the two diseases appears unsupported.

Identifiants

pubmed: 33098006
doi: 10.1007/s00404-020-05840-8
pii: 10.1007/s00404-020-05840-8
pmc: PMC7854401
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-53

Commentaires et corrections

Type : CommentIn

Références

Gynecol Obstet Invest. 2018;83(4):313-328
pubmed: 29874641
Ann Surg Oncol. 2014 Dec;21(13):4246-55
pubmed: 25001096
Facts Views Vis Obgyn. 2018 Sep;10(3):147-152
pubmed: 31191849
Int J Gynecol Cancer. 2018 Jan;28(1):145-151
pubmed: 29040186
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:69-74
pubmed: 24965983
Pathol Oncol Res. 2020 Oct;26(4):2049-2056
pubmed: 31444708
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1185-1190
pubmed: 31030493
Future Oncol. 2012 Jun;8(6):713-22
pubmed: 22764769
Int J Clin Exp Pathol. 2018 Feb 01;11(2):956-962
pubmed: 31938189
Sci Rep. 2020 Feb 27;10(1):3621
pubmed: 32108150
J Minim Invasive Gynecol. 2016 Feb 1;23(2):164-85
pubmed: 26427702
Best Pract Res Clin Obstet Gynaecol. 2006 Aug;20(4):511-21
pubmed: 16563870
Hum Reprod. 1997 Jun;12(6):1275-9
pubmed: 9222017
Exp Ther Med. 2017 Oct;14(4):3805-3811
pubmed: 29042983
Lancet. 2005 Aug 6-12;366(9484):491-505
pubmed: 16084259
Gynecol Oncol. 2016 May;141(2):211-217
pubmed: 26920107
Clin Exp Obstet Gynecol. 2007;34(3):163-7
pubmed: 17937092
Hum Reprod Update. 2020 Apr 15;26(3):392-411
pubmed: 32097456
Hum Reprod. 2012 Dec;27(12):3432-9
pubmed: 23001775
J Minim Invasive Gynecol. 2016 May-Jun;23(4):476-88
pubmed: 26772777
Pathol Oncol Res. 2020 Jul;26(3):1417-1427
pubmed: 32377987
Ann Diagn Pathol. 2007 Aug;11(4):252-7
pubmed: 17630108
Int J Gynecol Cancer. 2014 Oct;24(8):1429-33
pubmed: 25188882
J Minim Invasive Gynecol. 2016 Jan;23(1):53-61
pubmed: 26282516
J Natl Cancer Inst. 2000 Jun 7;92(11):924-30
pubmed: 10841828
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
Arch Gynecol Obstet. 2019 Jan;299(1):47-53
pubmed: 30519753
Am J Obstet Gynecol. 2012 Nov;207(5):417.e1-6
pubmed: 22840974
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Anticancer Res. 2005 May-Jun;25(3c):2423-8
pubmed: 16080469
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2840-7
pubmed: 16364998
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Arch Gynecol Obstet. 2019 Nov;300(5):1147-1154
pubmed: 31531779
Medicine (Baltimore). 2017 Oct;96(43):e8336
pubmed: 29069006
Tumori. 2018 Jan-Feb;104(1):60-65
pubmed: 29192745
Cancer Detect Prev. 2004;28(2):94-8
pubmed: 15068832
Arch Gynecol Obstet. 2017 Jun;295(6):1459-1468
pubmed: 28444512
J Minim Invasive Gynecol. 2011 Jul-Aug;18(4):428-37
pubmed: 21622029
Am J Clin Pathol. 2020 Jan 1;153(1):40-48
pubmed: 31433834

Auteurs

Antonio Raffone (A)

Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.

Renato Seracchioli (R)

Gynecology and Human Reproduction Physiopathology, Dipartimento Di Scienze Mediche E Chirurgiche (DIMEC), IRCCS S. Orsola Hospital, University of Bologna, Bologna, Italy.

Diego Raimondo (D)

Gynecology and Human Reproduction Physiopathology, Dipartimento Di Scienze Mediche E Chirurgiche (DIMEC), IRCCS S. Orsola Hospital, University of Bologna, Bologna, Italy. die.raimondo@gmail.com.

Manuela Maletta (M)

Gynecology and Human Reproduction Physiopathology, Dipartimento Di Scienze Mediche E Chirurgiche (DIMEC), IRCCS S. Orsola Hospital, University of Bologna, Bologna, Italy.

Antonio Travaglino (A)

Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine, University of Naples Federico II, Naples, Italy.

Ivano Raimondo (I)

Gynecologic and Obstetric Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
School in Biomedical Sciences, University of Sassari, Sassari, Italy.

Ilaria Giaquinto (I)

Gynecology and Human Reproduction Physiopathology, Dipartimento Di Scienze Mediche E Chirurgiche (DIMEC), IRCCS S. Orsola Hospital, University of Bologna, Bologna, Italy.

Benedetta Orsini (B)

Gynecology and Human Reproduction Physiopathology, Dipartimento Di Scienze Mediche E Chirurgiche (DIMEC), IRCCS S. Orsola Hospital, University of Bologna, Bologna, Italy.

Luigi Insabato (L)

Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine, University of Naples Federico II, Naples, Italy.

Massimiliano Pellicano (M)

Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.

Fulvio Zullo (F)

Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH